Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The peripheral tissue insulin sensitivity pathway refers to the molecular signaling cascade by which insulin regulates glucose uptake, metabolism, and storage in peripheral tissues—primarily skeletal muscle, adipose (fat) tissue, and liver. Key components include the Insulin Receptor (INSR), Insulin Receptor Substrates (IRS1/2), and downstream signaling pathways like PI3K–Akt/PKB and MAPK. Tissue-specific actions involve glucose uptake/storage in muscle, suppression of lipolysis/lipid storage in adipose tissue, and suppression of gluconeogenesis/glycogen/lipid synthesis in the liver. Regulation occurs via negative feedback, dephosphorylation, and receptor internalization. Peripheral tissue insulin resistance is a hallmark of type 2 diabetes and obesity. Therapeutic modulation includes drugs like metformin and lifestyle interventions like exercise.
Enhancement of insulin sensitivity in peripheral tissues
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peripheral Tissue Insulin Sensitivity Pathway.